Vandenbroucke JP - Search Results

1

Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.

de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. de Bruijn SF, et al. Among authors: vandenbroucke jp. BMJ. 1998 Feb 21;316(7131):589-92. doi: 10.1136/bmj.316.7131.589. BMJ. 1998. PMID: 9518910 Free PMC article.

2

Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group.

de Bruijn SF, Stam J, Vandenbroucke JP. de Bruijn SF, et al. Among authors: vandenbroucke jp. Lancet. 1998 May 9;351(9113):1404. doi: 10.1016/s0140-6736(05)79442-3. Lancet. 1998. PMID: 9593414 Clinical Trial. No abstract available.

3

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Vandenbroucke JP, van der Meer FJ, Helmerhorst FM, Rosendaal FR. Vandenbroucke JP, et al. BMJ. 1996 Nov 2;313(7065):1127-30. doi: 10.1136/bmj.313.7065.1127. BMJ. 1996. PMID: 8916702 Free PMC article. Review.

4

Survival in families with hereditary protein C deficiency, 1820 to 1993.

Allaart CF, Rosendaal FR, Noteboom WM, Vandenbroucke JP, Briët E. Allaart CF, et al. Among authors: vandenbroucke jp. BMJ. 1995 Oct 7;311(7010):910-3. doi: 10.1136/bmj.311.7010.910. BMJ. 1995. PMID: 7580547 Free PMC article.

5

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. van Hylckama Vlieg A, et al. Among authors: vandenbroucke jp. BMJ. 2009 Aug 13;339:b2921. doi: 10.1136/bmj.b2921. BMJ. 2009. PMID: 19679614 Free PMC article.

6

Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.

Vandenbroucke JP. Vandenbroucke JP. BMJ. 1998 Aug 22;317(7157):483-4. doi: 10.1136/bmj.317.7157.483. BMJ. 1998. PMID: 9712588 Free PMC article. No abstract available.

7

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Vandenbroucke JP, et al. Lancet. 1994 Nov 26;344(8935):1453-7. doi: 10.1016/s0140-6736(94)90286-0. Lancet. 1994. PMID: 7968118 Free article.

8

Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Bloemenkamp KW, et al. Among authors: vandenbroucke jp. Arch Intern Med. 2000 Jan 10;160(1):49-52. doi: 10.1001/archinte.160.1.49. Arch Intern Med. 2000. PMID: 10632304

9

Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation.

Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, Rosendaal FR. Vandenbroucke JP, et al. Am J Obstet Gynecol. 1997 Oct;177(4):887-91. doi: 10.1016/s0002-9378(97)70289-8. Am J Obstet Gynecol. 1997. PMID: 9369840 Review.

10

Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias.

Bloemenkamp KW, Rosendaal FR, Büller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP. Bloemenkamp KW, et al. Among authors: vandenbroucke jp. Arch Intern Med. 1999 Jan 11;159(1):65-70. doi: 10.1001/archinte.159.1.65. Arch Intern Med. 1999. PMID: 9892332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters